Merge Labs
PrivateLast Round
Seed
Jan 15, 2026
Est. Valuation
$850M
Total Funding Raised
$252M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Merge Labs is a neurotechnology company developing non-invasive brain-computer interface (BCI) technologies that utilize ultrasound and molecular engineering to bridge biological and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Merge Labs Comparables
Compare Merge Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bridge Neurotech | 84% | |
| Synaptrix Labs | 79% | |
| Kernel | 77% |
Merge Labs Funding Rounds
Historical fundraising activity
Merge Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Ventures | Seed |
| Bain Capital, LP | Seed |
| Interface Fund | Seed |
| Fifty Years | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 25% QoQ, from 40 to 50 employees.
- Jul 2, 2026
Grew 31% QoQ, from 32 to 42 employees.
Recent news
Latest coverage and updates
- is_developingSep 1, 2026
On Sep 1st '26, Merge begins a multi-year licensing deal with Butterfly Network and gains access to its Poseidon Ultrasound-on-Chip technology to develop ultrasound-based brain-computer interfaces.
Merge Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Merge Labs's valuation, stock price, and market status.
Is Merge Labs a public or private company?
Merge Labs is a private company.
What is the current stock price of Merge Labs?
Merge Labs is a private company, so its shares have no public market price. Caplight tracks Merge Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Merge Labs worth (valuation)?
Merge Labs's valuation is estimated at $850.0M based on funding round data.
Can I buy Merge Labs stock?
Merge Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Merge Labs's last funding round?
Merge Labs's most recent funding round was Seed on January 15, 2026.
Who are the main investors in Merge Labs?
Key investors in Merge Labs include Bain Capital Ventures, Bain Capital, LP.
Will Merge Labs IPO soon?
No public IPO plans have been announced for Merge Labs.
How can I track Merge Labs secondary market activity?
Caplight tracks bids, offers, and trades in Merge Labs's shares on secondary markets.